-
Diagnostics World News | Telemedicine is probably not appreciably lowering the overall cost of patient care, according to Maria Turner, managing director at global management consulting firm AArete. Post-pandemic, Turner expects the telemedicine landscape will look a lot different than it does today.
Sep 10, 2020
-
Diagnostics WorldOncologists often make decisions about diagnostic tests with very little information to go on, and the dearth of high-quality evidence has made it difficult for both doctors and institutions to advance personalized medicine without a roadmap for overcoming the challenges, which the Personalized Medicine Coalition (PMC) has been developing. At the recent Next Generation Dx Summit, speakers explored how oncologists choose and evaluate such tests.
Sep 8, 2020
-
Diagnostics World News | A CRISPR-based assay and smartphone-based molecular test, the role of children in viral spread, using pressure to concentrate samples, a patient scoring system, timetable on retesting, two tests are better than one, and deep dives on older patients. Plus, the COVID-19 Symptom Data Challenge and nine more companies get NIH grants to scale up COVID-19 testing.
Sep 4, 2020
-
Diagnostics World News | The regulatory framework around drug and diagnostic co-development, and how to overcome the inevitable hurdles, was the subject of multiple presentations at the 12th Annual Next Generation Dx Summit held virtually last week.
Sep 1, 2020
-
Diagnostics World News | Census data shows COVID-19 follows HIV patterns of racial segregation, how virtual imaging studies can help, inflammation markers that predict severe disease, and models of early transmission. Plus, two EUAs for saliva tests and back-to-work testing.
Aug 28, 2020
-
Diagnostics World News | Day two of the Next Generation Dx Summit was highlighted by a spirited panel discussion on the lessons learned during the pandemic, as well as some practical guidance on the development of next-generation diagnostics.
Aug 26, 2020
-
Diagnostics World News | Yesterday, the Centers for Medicare & Medicaid Services (CMS) announced regulatory changes that require nursing homes to test staff and offer testing to residents for COVID-19. Laboratories and nursing homes using point-of-care testing devices will be required to report diagnostic test results as required by the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). The new rules also require hospitals to provide COVID-19 cases and related data to the U.S. Department of Health and Human Services (HHS).
Aug 26, 2020
-
Diagnostics World News | At day one of the Next Generation Dx Summit, MD Anderson Cancer Center highlighted “unprecedented opportunities” for blood-based biomarkers in cancer detection, Merck weighed in on the regulatory environment for companion diagnostics, FDA gave an update on selected precision oncology initiatives of the agency, and more.
Aug 25, 2020
-
Diagnostics World News | August featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Adaptive Biotechnologies, Strata Oncology, and more.
Aug 24, 2020